Unexpected development of tongue squamous cell carcinoma after sclerotherapy for the venous malformation: a unique case report and literature review

Table 1 Information of patients who suffered carcinoma development after sclerotherapy

Case	Patient age(years)/sex	Lesion location	Primary lesion	Duration of carcinoma development (months)	Sclerosants used	Total dose	Reference
1	54.7 ± 6/M	Esophagus	Esophageal varices	12-30	Polidocanol	90-310 ml	[3]
2	Unknown	Esophagus	Esophageal varices	24	Sodium morrhuate	10 ml	[4]
3	Unknown	Esophagus	Esophageal varices	21	Ethanolamine oleate	45.5 ml	[4]
4	52/M	Esophagus	Esophageal varices	36	Polidocanol	117 ml	[5]
5	58.3 ± 5.0/Unknown	Esophagus	Esophageal varices	9-33	Ethanolamine oleate	51.0 ± 18.9 ml	[6]
6	56/M	Esophagus	Esophageal varices	54	Ethanolamine oleate	70 ml	[7]
7	Unknown	Esophagus	Esophageal varices	5-48	Sotradecol	30 ml	[8]
8	47/F	Kidney	Simple renal cyst	36	Minocycline and Ethanol	200 mg	[9]
9	65/F	Tongue	Venous malformation	65	Pingyangmycin and Sodium morrhuate	174 mg	Present case

ISSN: 1746-1596